SCHAAF DRUGS, LLC
Entity uei:LSEHGNVLAVX5 · UEI LSEHGNVLAVX5
Obligations by fiscal year
Awards (3)
| 36C25025N0283↗ EXERCISING OPTION YEAR 2 01/06/2024 - 01/05/2025 | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jan 6, 2025 – Jan 5, 2026 | $120K | — | 0 |
| 36C25026N0185↗ OY3 (PYP-TC99M ATRIAL AMYLOIDOSIS) CANNOT BE LOCATED ON THE PRICE SCHEDULE FOUND THAT THIS ITEM WAS INADVERTENTLY LEFT OFF THE PRICE LIST | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Jan 6, 2023 – Jan 5, 2027 | $119K | — | 0 |
| 36C25024N0234↗ EXERCISING OPTION YEAR ONE FOR RADIOPHARMS | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Jan 6, 2024 – Jan 5, 2024 | $117K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- SCHAAF DRUGS, LLC
LSEHGNVLAVX5· seen 9×